{"nct_id":"NCT06220201","title":"A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-03-28","start_date_type":"ACTUAL","primary_completion_date":"2027-07-15","primary_completion_date_type":"ESTIMATED","completion_date":"2027-07-15","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["BMY"]}